| Literature DB >> 19763667 |
Senol Kobak1, Recep Savas, Fahrettin Oksel, Eker Doganavsargil.
Abstract
Cyclosporine A (CsA) is an immunosuppressive agent used for the prevention of graft rejection during organ and bone marrow transplantation. CsA is also used for the treatment of various inflammatory rheumatic diseases. Although different side effect profiles have been reported, nephrotoxicity, renal vascular damage, hypertension, and gingival hypertrophy are among the most commonly encountered side effects. The development of massive fibrosis in the neck associated with CsA in a 30-year-old male patient with Still's disease is presented herein. Significant regression was observed after the discontinuation of CsA.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19763667 DOI: 10.1007/s10067-009-1275-z
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 2.980